Discovering old motorcycles/ מאת 455886 Crowley, R. E.

Die design fundamentals מאת 335574 Paquin, J. R., Crowley, R. E.

James Joyce's Unpublished Letters [online resource] מאת Van Hulle, D, Spoo, R, Groden, M, Dettmar, K, Crowley, R, Brockman, WS, Batinić, J, Alonso, S

Androgenemic Phenotype Predicts Metabolic Disease and Androgen Burden in Polycystic Ovary Syndrome מאת O'Reilly, M, Taylor, A, Crabtree, N, Crowley, R, Hughes, B, Stewart, P, Tomlinson, J, Arlt, W

SFRP2 is associated with increased adiposity and VEGF expression. מאת Crowley, R, O'Reilly, M, Bujalska, I, Hassan-Smith, Z, Hazlehurst, J, Foucault, D, Stewart, P, Tomlinson, J

Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. מאת O'Reilly, M, Taylor, A, Crabtree, N, Hughes, B, Capper, F, Crowley, R, Stewart, P, Tomlinson, J, Arlt, W

Longitudinal changes in glucocorticoid metabolism are associated with later development of adverse metabolic phenotype. מאת Crowley, R, Hughes, B, Gray, J, McCarthy, T, Hughes, S, Shackleton, C, Crabtree, N, Nightingale, P, Stewart, P, Tomlinson, J

Preparing accessible and understandable clinical research participant information leaflets and consent forms: a set of guidelines from an expert consensus conference מאת Coleman, E, O'Sullivan, L, Crowley, R, Hanbidge, M, Driver, S, Kroll, T, Kelly, A, Nichol, A, McCarthy, O, Sukumar, P, Doran, P

Increased central adiposity and decreased subcutaneous adipose tissue 11β‐hydroxysteroid dehydrogenase type 1 are associated with deterioration in glucose tolerance—A longitudinal... מאת Crowley, R, Woods, C, Hughes, B, Gray, J, McCarthy, T, Taylor, A, Gathercole, L, Shackleton, C, Crabtree, N, Arlt, W, Stewart, P, Tomlinson, J

Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alstrom syndrome. מאת Gathercole, L, Hazlehurst, J, Armstrong, M, Crowley, R, Boocock, S, O'Reilly, M, Round, M, Brown, R, Bolton, S, Cramb, R, Newsome, P, Semple, R, Paisey, R, Tomlinson, J, Geberhiwot, T

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Contro... מאת Portale, A, Carpenter, T, Brandi, M, Briot, K, Cheong, H, Cohen-Solal, M, Crowley, R, Jan De Beur, S, Eastell, R, Imanishi, Y, Imel, E, Ing, S, Ito, N, Javaid, M, Kamenicky, P, Keen, R, Kubota, T, Lachmann, R, Perwad, F, Pitukcheewanont, P, Ralston, S, Takeuchi, Y, Tanaka, H, Weber, T, Yoo, H, Zhang, L, Theodore-Oklota, C, Mealiffe, M, San Martin, J, Insogna, K